Novartis To Launch Exforge In September 2007
This article was originally published in The Pink Sheet Daily
Executive Summary
Company cannot market the hypertension combination drug until expiration of exclusivity for Pfizer’s Norvasc.
You may also be interested in...
Novartis’ Exforge To Launch By End Of June
Launch timeframe for the combination of firm’s Diovan and Pfizer’s Norvasc is a few months earlier than previously expected due to recent invalidation of Norvasc patent.
Novartis’ Exforge To Launch By End Of June
Launch timeframe for the combination of firm’s Diovan and Pfizer’s Norvasc is a few months earlier than previously expected due to recent invalidation of Norvasc patent.
Generic Norvasc May Launch Sooner Than Expected Following Appellate Court Ruling
Pfizer’s hypertension treatment was predicted to go generic in September.